B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.
about
Perforin-dependent elimination of dendritic cells regulates the expansion of antigen-specific CD8+ T cells in vivo.A new TLR2 agonist promotes cross-presentation by mouse and human antigen presenting cells.CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68.B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice.CD40-activated B cells can be generated in high number and purity in cancer patients: analysis of immunogenicity and homing potential.Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen.CD40-activated B cells as antigen-presenting cells: the final sprint toward clinical application.RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma.Inflammation enhances the vaccination potential of CD40-activated B cells in mice.IL-6 production by dendritic cells is dispensable for CD8+ memory T-cell generation.Complement opsonization enhances friend virus infection of B cells and thereby amplifies the virus-specific CD8+ T cell responseAbortive activation precedes functional deletion of CD8+ T cells following encounter with self-antigens expressed by resting B cells in vivo.
P2860
Q34248293-C60EA4BA-FE11-416B-89E4-A36D6C3A5202Q36256534-AB25B40C-661B-4E9D-A330-EA214551A761Q36949825-E7951EB8-A87B-4B16-9839-6FAF1DD36DBBQ37069120-5BE4395B-1827-454F-AC3B-906DD333DA14Q37336918-540717E9-EABD-4A94-90AB-041BD0AE078DQ37440696-CB2C276C-1D62-4926-B74E-CBF1D5315C4FQ38113268-B5A58AB9-F4CF-46D0-A096-BD76E38197BFQ40002875-5B416E38-C42F-42C4-AF92-5B3FAA8D8A6EQ40441002-A5BFE2BA-0A44-4B3D-9035-23B3A801BAA7Q41482202-A3283CC7-3D12-4CCD-9274-E58F094A77B8Q41773067-9BA5D16B-EF39-4DB7-9560-6BBACE70B743Q44577092-A43DFDA2-8545-4D72-A76B-C711F5660266
P2860
B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
B-Lymphocytes activated by CD4 ...... activation of CD8(+) T-cells.
@en
type
label
B-Lymphocytes activated by CD4 ...... activation of CD8(+) T-cells.
@en
prefLabel
B-Lymphocytes activated by CD4 ...... activation of CD8(+) T-cells.
@en
P2860
P1476
B-Lymphocytes activated by CD4 ...... t activation of CD8(+) T-cells
@en
P2093
Ritchie DS
Ronchese F
P2860
P304
P356
10.1111/J.0300-9475.2004.01517.X
P577
2004-12-01T00:00:00Z